Melatonin: Does It Actually Work?

What Is Melatonin?

Melatonin is a hormone your brain makes every night. Your pineal gland starts producing it when it gets dark and stops when light hits your eyes. It tells your body when to sleep. Not how deeply to sleep. That distinction matters.

You can also take it as a supplement. It’s the most popular sleep aid in the United States. About 3.1 million Americans use it regularly. But melatonin isn’t a sleeping pill. It’s a timing signal. It shifts your internal clock, and that’s what makes it useful for things like jet lag and delayed sleep.

Melatonin was first isolated from cow pineal glands in 1958. It has no traditional medicine history. Unlike herbs that have been used for centuries, melatonin is a modern discovery. MIT patented it as a sleep aid in 1995, and it’s been one of the most studied supplements since. We analyzed 137 studies across 10 claims. Three of those claims hold up well. Several have potential. A few are marketing fluff.

The Evidence, Claim by Claim

The sections below break down each claim with real numbers from published meta-analyses. Every effect size, confidence interval, and study count comes from peer-reviewed research. We start with the strongest claims and work down to the weakest.

Reduces Time to Fall Asleep

Verdict: Works | Grade A | 19 studies, 1,683 people

This is melatonin’s best-studied use. A meta-analysis pooled 19 randomized controlled trials with 1,683 people. Melatonin reduced time to fall asleep by about 7 minutes (fixed-effects) to 10 minutes (random-effects).

That sounds small. But for someone lying awake for 45 minutes every night, shaving off 10 minutes is meaningful. The effect is consistent across studies. Most agree on the direction.

A 2024 update with 26 trials confirmed the finding. They found the optimal dose is around 4mg, taken 3 hours before your target bedtime. But lower doses (0.5-1mg) still work well. No publication bias was detected, which means the positive results aren’t just cherry-picked studies.

The effect is stronger in people who already have trouble falling asleep. If you fall asleep fine on your own, you won’t notice much difference.

Prevents Jet Lag

Verdict: Works | Grade A | 10 studies, 691 people

This is where melatonin really shines. A Cochrane review (the gold standard for evidence) looked at 10 trials with about 691 travelers.

The number-needed-to-treat was 2. That means for every 2 people who take melatonin for jet lag, 1 will benefit. In medicine, that’s an excellent result. Most drugs have NNTs of 5-20.

Eight out of 10 trials were positive. It works best for eastward travel across 5 or more time zones. Doses between 0.5mg and 5mg all worked. Fast-release tablets beat slow-release.

The main limitation is that most trials are from the 1990s. But jet lag biology hasn’t changed. Your circadian system still responds to melatonin the same way it did 30 years ago.

Prevents Migraines

Verdict: Works | Grade A | 9 studies, 788 people

This is melatonin’s most underrated use. 9 trials with 788 people found it reduces migraine headache days by about 1.5 per month. It also cuts attack duration by 5 hours, reduces pain severity, and lowers painkiller use.

Patients on melatonin were 38% more likely to see their migraines cut in half. A large network meta-analysis with 25 trials and 4,499 patients ranked melatonin 3mg immediate-release as the top choice when balancing efficacy, side effects, and dropout rates.

It’s less powerful than amitriptyline but much better tolerated, with 51% less sleepiness. Low heterogeneity (I2 = 0%) means the studies strongly agree.

Formulation is critical here. 3mg immediate-release works. 2mg sustained-release doesn’t. One specific trial tested sustained-release and found zero difference from placebo. If you try melatonin for migraines, get the right form.

Improves Overall Sleep Quality

Verdict: Maybe | Grade B | 23 studies

This is where things get less impressive. 23 studies found melatonin improved sleep quality scores by 1.24 points on the PSQI scale. That’s a real but modest effect.

The results varied a lot between studies (I2 = 80.7%). It worked best in people with metabolic conditions like diabetes (improvement of 2.74 points) and respiratory diseases like COPD (2.20 points). It didn’t help much for mental health conditions or brain diseases.

A 2025 scoping review covering 57 systematic reviews found that 80.9% favored melatonin. But “favored” doesn’t mean “dramatic improvement.” Don’t expect melatonin to transform your sleep quality.

Acts as an Antioxidant

Verdict: Maybe | Grade B | 12 studies, 521 people

12 trials with 521 people found melatonin increases total antioxidant capacity and reduces markers of oxidative damage. The effects are moderate to large. Three independent meta-analyses all found the same direction of effect, which adds confidence.

But there’s a catch. Nearly all studies used high doses (6-10mg) in people with metabolic diseases like diabetes. We don’t know if healthy people get the same benefit at normal doses. And no studies measured clinical outcomes like disease prevention. The antioxidant boost is real in lab numbers, but its practical meaning is unclear.

Reduces Inflammation (Not “Immune Boosting”)

Verdict: Maybe | Grade B | 31 studies, 1,517 people

31 trials with about 1,500 people found melatonin reduces inflammatory markers like IL-6 and IL-1beta. Multiple large meta-analyses consistently show anti-inflammatory effects.

But here’s the problem with how this gets marketed. Reducing inflammation isn’t the same as “boosting immunity.” There’s no meta-analysis on direct immune cell counts or immune function tests. Some results even lost significance when the biggest outliers were removed.

Melatonin reduces inflammation. That’s real. It doesn’t supercharge your immune system. That’s marketing.

Reduces Cancer Treatment Side Effects

Verdict: Maybe | Grade B | 30 studies, 5,093 people

A 2025 Cochrane review of 30 trials with 5,093 patients found melatonin may cut cancer-related fatigue in half (risk ratio 0.46). That sounds impressive. But the overall evidence quality is very low to moderate.

Older meta-analyses showed dramatic benefits for survival and tumor remission. But most of those studies came from one Italian lab with no blinding. When better-designed recent trials tested melatonin, the results were much less exciting.

The fatigue finding has moderate certainty. The survival and tumor benefits from older research are likely inflated. The truth is probably somewhere in between. Don’t take melatonin to treat cancer. But if you’re going through chemotherapy, talk to your oncologist about whether it might help with fatigue.

Protects Brain Health and Alzheimer’s

Verdict: Maybe | Grade B | 9 studies

9 studies found melatonin may slightly improve cognitive scores in people with mild Alzheimer’s. The effect is about 1.8 points on the MMSE, which is modest but real. A 2024 network analysis controversially claimed melatonin outperformed new Alzheimer’s drugs like donanemab and lecanemab. But that study had serious limitations.

Here’s the important part. A Cochrane review found no benefit at all for people with moderate-to-severe dementia. The positive finding applies only to mild cases treated for more than 12 weeks. The Alzheimer’s Association explicitly says there’s no evidence melatonin prevents dementia.

A NIH trial is underway. Until those results come in, don’t take melatonin expecting to prevent Alzheimer’s.

Lowers Blood Pressure

Verdict: Maybe | Grade B | 63 studies, 3,157 people

A 2025 mega-analysis of 63 trials with 3,157 people found melatonin lowers systolic blood pressure by about 2.3 mmHg. That’s small. For comparison, cutting salt intake drops BP by 5-6 mmHg.

The effect was stronger in people with obesity or metabolic syndrome. But here’s the catch. Controlled-release melatonin lowers BP, while immediate-release may actually raise it. One study in patients on calcium-channel blockers found melatonin increased blood pressure by 6.5 mmHg.

The formulation and drug interactions matter a lot. Don’t take melatonin to treat high blood pressure without medical supervision.

Relieves IBS and GERD Symptoms

Verdict: Maybe | Grade B | 4 studies, 115 people

4 small trials with 115 IBS patients found melatonin at 3mg significantly improved overall IBS severity, pain, and quality of life. The effect size is medium-to-large. All studies used the same dose (3mg at bedtime).

There’s a biological basis for this. Your gut makes 400 times more melatonin than your brain. But the evidence is thin. Only 4 tiny studies.

For GERD, the famous study showing melatonin worked as well as omeprazole combined it with tryptophan and B vitamins. You can’t credit melatonin alone. And one important caution: melatonin may worsen gut inflammation in people with IBD. Don’t replace standard IBS or GERD treatments based on this limited evidence.

Slows Aging and Promotes Longevity

Verdict: No Evidence | Grade D | 0 human studies

There are zero human trials measuring lifespan or aging biomarkers as a primary outcome. This claim comes from animal studies where fruit flies lived about 33% longer with melatonin. But mouse studies are inconsistent, and some showed increased tumor risk.

The marketing angle goes like this: melatonin production drops as you age, so replacing it should slow aging. That logic doesn’t hold up. Gray hair increases with age too, but dyeing it won’t make you younger.

An AHA 2025 observational analysis actually found long-term melatonin users had doubled all-cause mortality (HR 2.09). That almost certainly reflects sicker people being more likely to use melatonin, not melatonin causing death. But it’s definitely not evidence for longevity.

There’s no scientific basis for taking melatonin to live longer.

Who Should NOT Take Melatonin

Melatonin is one of the safest supplements out there. But it’s not for everyone.

Don’t take it if you’re pregnant or breastfeeding. There isn’t enough safety data for these groups.

Be careful if you have a seizure disorder. Melatonin may lower the seizure threshold in some people. Some case reports suggest it increased seizure frequency in children.

Avoid it if you have autoimmune conditions. Melatonin stimulates immune function (NK cells, IL-2, T-helper cells), which is the opposite of what you want when your immune system is already overactive.

Children should only use it under medical supervision. It’s widely given to kids, but long-term safety data in children is limited.

Drug Interactions to Know About

High severity:

Fluvoxamine (Luvox) is the biggest concern. It blocks CYP1A2, the main enzyme that breaks down melatonin. Your blood levels can jump 12-17x higher, causing extreme drowsiness. Avoid combining these or reduce your melatonin dose dramatically under a doctor’s guidance.

Calcium channel blockers (nifedipine, amlodipine) also interact badly. Melatonin opposes their blood pressure lowering effect. One trial found 5mg melatonin raised systolic BP by 6.5 mmHg in patients on nifedipine.

Moderate severity:

Blood thinners like warfarin may interact because melatonin has mild anticoagulant effects. Monitor your INR more often if you combine them.

Diabetes medications need caution too. Melatonin can lower blood sugar on its own, so combining it with insulin or metformin may cause hypoglycemia.

If you take immunosuppressants after an organ transplant, avoid melatonin. It stimulates the immune function those drugs are trying to suppress.

Oral contraceptives raise melatonin blood levels 4-5x by inhibiting CYP1A2. You may not need supplemental melatonin while on birth control. If you do, use a lower dose. Your birth control effectiveness isn’t affected.

Beta blockers actually suppress your natural melatonin production by 40-50%. That’s why they often cause insomnia. Supplementing with 2.5mg melatonin may help restore sleep. This is one of the few potentially beneficial drug interactions.

SSRIs and SNRIs add mild sedation. Low-dose melatonin is generally safe with most SSRIs. There’s a rare risk of serotonin syndrome. Watch for confusion, rapid heart rate, or muscle twitching.

Common Side Effects

Most people tolerate melatonin well. The most common complaint is morning grogginess, which usually means your dose is too high. Vivid dreams or nightmares happen because melatonin increases REM sleep. Headache, mild dizziness, and nausea can occur at very high doses. All of these go away when you lower the dose or stop taking it.

The Bottom Line

Melatonin is one of the most studied supplements available. Three claims hold up well: it helps you fall asleep faster, it prevents jet lag, and it reduces migraine frequency. The evidence for all three is strong and consistent.

Several other claims have potential but aren’t proven. Sleep quality improves modestly. Antioxidant and anti-inflammatory effects show up in lab markers but don’t clearly translate to disease prevention. Brain health benefits are limited to mild Alzheimer’s cases. Blood pressure and gut health effects are real but small, inconsistent, or based on very few studies.

One claim has zero human evidence: anti-aging. Don’t take melatonin to live longer.

The most common mistake people make is taking too much. Your body makes less than 1mg per night. Most studies tested doses of 0.3-0.5mg for sleep, 3mg for migraines, and up to 5mg for jet lag. Immediate-release tablets match most of the positive research. Melatonin is a timing signal, not a sedative. It works best paired with good sleep habits like a dark room, consistent schedule, and limited screen time before bed. Talk to your doctor about the right dose for you.